Reporting to the VP, Clinical Operations, CARGO is seeking aClinical Trial Associate to play a crucial part in the Study Management Team. The successful candidate will coordinate various administrative aspects of the sponsor’s project management and oversight activities. The individual will partner closely with the Clinical Project Managers and Clinical Research Associates to provide administrative expertise to multiple clinical study management teams. This role will help to define and implement meaningful oversight of CROs by supporting study start-up activities, tracking study progress, overseeing the Trial Master File quality and completeness, maintaining meeting agendas and minutes, and implementing learnings/sharing knowledge with other study management teams. This team member will work with a high degree of independence and provide administrative support and guidance to help the team achieve high performance and quality project deliverables.
The role is based in San Carlos, CA.
WHAT YOU’LL DO AT CARGO THERAPEUTICS
Support 1 or more Study Management Teams (SMTs), including scheduling meetings, distributing agendas, rooms, participants, and meeting minutes
Document outstanding action items with expected completion dates and responsible individuals
Support SMT risk management discussions, follow-up, and documentation
Track and maintain study information and report on study progress; maintain and disseminate basic study tracking information including, but not limited to: visit reports, regulatory documents, site contact lists, team contact lists, and vendor lists
Obtain, review, process, and track study related documents (CVs, FDA 1572s, lab certifications, IRB approvals, contracts, protocols, etc.) in addition to tracking and providing IRB/IEC submission documentation and other supplementary documentation, as appropriate
Support Essential Document Packet (EDP) review and approval process
Support Informed Consent Form (ICF) development, review and approval process
Ensure a high-quality filing structure and archive of trial documents including maintenance and oversight on the completeness of the Trial Master File (TMF) in accordance with SOP requirements
Support preparation of materials for investigator meetings, workshops, and study manuals
Lead development of study newsletters
Support onboarding of new CTA team members
Support process improvement initiatives
Build a strong relationship with investigators (if applicable) and site staff; ensure our sites get the support they need
Perform study start-up activities
Site and vendor management including oversight of preparation, shipment, and management of study supplies to sites
Provide data management support by ensuring timely data entry and centralized data monitoring in preparation for monitoring visits
Create and manage trackers and logs for oversight of Clinical Trials
Ensure a high-quality filing structure and archival of trial documents
THE RIGHT STUFF: Required Experience & Qualifications
Bachelor’s degree in health care, life sciences or related field
2+ years’ experience as a CTA or similar role in a biotechnology or pharmaceutical company supporting Clinical Trial conduct
History of full spectrum meeting management
Successful at maintaining study information and reporting study progress
Excellent interpersonal, organizational, problem-solving, and written/verbal communication/influence skills
Confidence and experience of effectively working/leading/influencing a wide variety of medical, research and administrative personnel within and outside CARGO
Experience working with Trial Master Files and study related documentation
Adept in Microsoft Office Suite (Excel, PowerPoint, Word, etc.)
Proficient in problem solving and time management
Independently motivated and detail-oriented
PAY RANGE
The combined pay range for this role is $88,000 - $121,000. Title and salary will be based on our assessment of skills and experience relevant to our needs for the role.
ABOUT CARGO THERAPEUTICS
CARGO Therapeutics, Inc. is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. CARGO’s programs, platform technologies, and manufacturing strategy are designed to directly address the limitations of approved cell therapies, including limited durability of effect, safety concerns and unreliable supply. CARGO is currently evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor (CAR) T-cell therapy candidate, in a potentially pivotal Phase 2 Clinical Trial in patients with large B-cell lymphoma (LBCL) whose disease relapsed or was refractory (R/R) to CD19 CAR T-cell therapy. CARGO also plans to evaluate CRG-022 in patients at earlier stages of disease, including LBCL and other hematologic malignancies. Beyond its lead program, CARGO is leveraging its proprietary cell engineering platform technologies to develop a pipeline of programs that incorporate multiple transgene therapeutic “cargo” designed to enhance CAR T-cell persistence and trafficking to tumor lesions, as well as to help safeguard against tumor resistance and T-cell exhaustion. CARGO’s founders are pioneers and world-class experts in CAR T-cell therapy, and its team has significant experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. For more information, please visit the CARGO Therapeutics website at https://cargo-tx.com/.
Join us to help make a difference!
EEO & EMPLOYMENT ELIGIBILITY
CARGO Therapeutics, Inc. is committed to building a diverse, equitable, and inclusive company. We provide equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability, or veteran status. CARGO Therapeutics, Inc. also complies with all applicable national, state, and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification required of applicable law.
CARGO Therapeutics requires all new hires to be fully vaccinated against COVID-19 as of their start date. This requirement is a condition of employment at CARGO Therapeutics, and it applies regardless of whether the position is located at a CARGO Therapeutics site or is fully remote. If you are unable to receive the vaccine due to a disability or serious medical condition, or because it is prohibited because of your sincerely held religious beliefs, you will have an opportunity to request a reasonable accommodation.